| 中國醫藥大學 |
2007-08 |
Berberine induces apoptosis in human HSC-3 oral cancer cells via simultaneous activation of the death receptor-mediated and mitochondrial pathway
|
(Chin-Chung Lin); 楊家欣(Yang Jai-Sing); (Jin-Tang Chen); (Shang Fan); (Hung-Pin Wang); (Jiun-Long Yang); (Chi-Cheng Lu); 高銘欽(Ming-Ching Kao); (An-Cheng Chang); (Hsu-Feng Lu); 鍾景光* |
| 中國醫藥大學 |
2007-07-31 |
標靶癌症治療之多功能奈米粒子的開發，子計畫二：奈米煤介之HER-2標靶癌症治療動物模式
|
高銘欽(Ming-Ching Kao) |
| 中國醫藥大學 |
2007-07-31 |
維甲酸誘導基因抑制神經膠原致癌基因表現的分子機制之研究
|
高銘欽(Ming-Ching Kao); 莊子超(Tzu-Chao Chuang) |
| 中國醫藥大學 |
2007-07-31 |
國人口腔癌之致病機制及治療之研究---運用敏感性干擾性核醣核酸技術找尋鑑定引發口腔癌的新穎生物指標蛋白分子
|
高銘欽(Ming-Ching Kao) |
| 中國醫藥大學 |
2007-07 |
Leptin-induced IL-6 production is mediated by leptin receptor, insulin receptor substrate-1, PI3K, Akt, NF-kB, and p300 pathway in microglia
|
湯智昕(Tang Chih-Hsin); 盧大宇(Lu, Dah-Yuu); 楊榮森(Yang RS); 蔡輝彥(Huei-Yann Tsai); 高銘欽(Ming-Ching Kao); 符文美(Fu Wen-Mei)*; 陳玉芳* |
| 中國醫藥大學 |
2007-04-14 |
Down-regulation of HER2 by IFN-gamma-induced RIG1 followed by PI3K/Akt/mTOR/VEGF pathway in ovarian cancer cells
|
(Chien-Chih Ou); (Shih-Chung Hsu); (Yin-Hui Hsieh); (Won-Ling Tzou); (Jia-Yaw Liu); 高銘欽(Ming-Ching Kao)* |
| 中國醫藥大學 |
2007-03-17 |
A proteomics approach to the molecular mechanism of tumor inhibition by Ganoderma tsugae extracts in human ovarian cancer SKOV-3 cells
|
(Wang YC); (Hsu SC); (Kuo HP); (Tzou WL); (Yeh MH); (Lin YH); (Chen CS); 高銘欽(Ming-Ching Kao)* |
| 中國醫藥大學 |
2007-03 |
ROS Mediates Baicalin-induced Apoptosis in Human Promyelocytic Leukemia HL-60 Cells through the Expression of the GADD153 and Mitochondria-dependent Pathway.
|
(Lu H. F.); (Hsueh S. C.); (Ho Y. T.,); 高銘欽(Ming-Ching Kao); 楊家欣; (Chiu T. T.,); (Huang S. Y.,); (Lin C. C.); 鍾景光* |
| 中國醫藥大學 |
2006-10 |
Antizyme, a natural ornithine decarboxylase inhibitor, induces apoptosis of haematopoietic cells through mitochondrial membrane depolarization and caspases' cascade
|
(Liu GY); (Liao YF); (Hsu PC); (Chang WH); (Hsieh MC); (Lin CY); (Hour TC); 高銘欽(Ming-Ching Kao); (Tsay GJ); (Hung HC)* |
| 中國醫藥大學 |
2006-07-31 |
評估胞質型神經膠原致癌蛋白在國人大腸直腸癌腫瘤中之角色
|
高銘欽(Ming-Ching Kao); 許來發(Lai-Fa Hsu) |
| 中國醫藥大學 |
2006-07-19 |
supression of colorectal tumor growth by Ganoderma tsugae extract causes G2/M arrest
|
高銘欽(Ming-Ching Kao)*; 許世忠(Shih-Chung Hsu); 王文奇(Vinchi Wang); 莊子超(Tzu-Chao Chuang); 劉嘉燿(Jia-Yaw Liu); 陳精祥(Chin-Shiung Chen); 林松洲(Sun-Chow Lin) |
| 中國醫藥大學 |
2006-03 |
Increasing ornithine decarboxylase activity is another way of prolactin preventing methotrexate-induced apoptosis: crosstalk between ODC and BCL-2
|
(Hsu PC); (Hour TC); (Liao YF); (Hung YC); (Liu CC); (Chang WH); 高銘欽(Ming-Ching Kao); (Tsay GJ); (Hung HC); (Liu GY)* |
| 中國醫藥大學 |
2006-01 |
Gene Transfer Mediated by Sphingosine/Dioleoylphosphatidylethanolamine Liposomes in the Presence of Poloxamer 188
|
(Law SL); (Chuang TC); 高銘欽(Ming-Ching Kao); (Lin YS); (Huang KJ) |
| 中國醫藥大學 |
2005-12-31 |
臺灣栽培靈芝在血管增生抑制效能上之癌症治療研究
|
高銘欽(Ming-Ching Kao) |
| 中國醫藥大學 |
2005-08 |
Ornithine decarboxylase prevents methotrexate-induced apoptosis by reducing intracellular reactive oxygen species production
|
(Huang CC); (Hsu PC); (Hung YC); (Liao YF); (Liu CC); (Hour CT); 高銘欽(Ming-Ching Kao); (Tsay GJ); (Hung HC); (Liu GY)* |
| 中國醫藥大學 |
2005-07-31 |
卵巢癌基因治療--微脂粒媒介病毒核抗原抑制卵巢癌患者癌細胞生長之動物試驗
|
劉嘉燿(Jha-Yao Liu); 高銘欽(Ming-Ching Kao) |
| 中國醫藥大學 |
2005-07-31 |
Gene chip approach to the molecular mechanism of repression of HER2/neu by the N-terminal domain of SV40 large T antigen
|
高銘欽(Ming-Ching Kao); 姜淑媛(Su-Yuan Jiang) |
| 中國醫藥大學 |
2005-07 |
Nitric oxide induces prion protein via MEK and p38 MAPK signaling
|
(Wang V); (Chuang TC); (Hsu YD); (Chou WY); 高銘欽(Ming-Ching Kao)* |
| 中國醫藥大學 |
2005-04-16 |
Human MnSOD suppresses HER2/neu-mediated breast cancer malignancy
|
高銘欽(Ming-Ching Kao)*; 莊子超(Tzu-Chao Chuang); 湯雅婷(Ya-Ting Tan); 林彥杏(Yeng-Shing Lin); 劉嘉燿(Jia-Yaw Liu); 林棋財(Chi-Tsai Lin) |
| 中國醫藥大學 |
2005-04 |
Clinicopathological relevance of HER2/neu and a related gene-protein cubic regression correlation in colorectal adenocarcinomas in Taiwan
|
(Li JW); (Chuang TC); (Yang AH); (Hsu CK); 高銘欽(Ming-Ching Kao)* |
| 中國醫藥大學 |
2005-02 |
Skeletal muscle dihydropyridine-sensitive calcium channel (CACNA1S) gene mutations in chinese patients with hypokalemic periodic paralysis
|
(Lin SH)*; (Hsu YD); (Cheng NL); 高銘欽(Ming-Ching Kao) |
| 中國醫藥大學 |
2005-01 |
Degradation of HER2/neu by apigenin induces apoptosis through cytochrome c release and caspase-3 activation in HER2/neu-overexpressing breast cancer cells
|
魏宗德; 高銘欽(Ming-Ching Kao); (Lin JK*)* |
| 中國醫藥大學 |
2004-12-31 |
台灣本土栽培靈芝在抗癌保健作用的效益評估
|
高銘欽(Ming-Ching Kao) |
| 中國醫藥大學 |
2004-11-09 |
Oncogene-targeting cancer gene therapy
|
高銘欽(Ming-Ching Kao)* |
| 中國醫藥大學 |
2004-09 |
Black tea polyphenol theaflavins inhibit aromatase activity and attenuate tamoxifen resistance in HER2/neu-transfected human breast cancer cells through tyrosine kinase suppression.
|
魏宗德; (Lee HH); 高銘欽(Ming-Ching Kao); (Lin JK*)* |
